Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PR Pharmaceuticals gains orphan drug status for PulmoLAR
The FDA granted orphan drug status upon review of an application containing data from both preclinical and in vitro studies demonstrating the multiple effects of 2-methoxyestradiol named 2ME
The FDA granted orphan drug status upon review of an application containing data from both preclinical and in vitro studies demonstrating the multiple effects of 2-methoxyestradiol named 2ME
HuMax-CD38 is a human IgG1,k antibody selected from a large panel of antibodies based on its ability to bind and to kill multiple myeloma tumor cells. The HuMax-CD38
An independent data monitoring committee completed a planned review of interim results and concluded that the data are unlikely to provide evidence of significant effect. No safety concerns
Scripps, based in La Jolla, California, is one of largest private, non-profit research organizations in the US. The investigation will follow up on earlier studies at Antigen Express
Bristol-Myers Squibb said that the divestiture of its Oncology Therapeutics Network (OTN) business reflects the company’s strategic focus on developing its pipeline and new product opportunities in unmet
The trial will evaluate the anti-tumor activity and tolerability of repeated doses of ADH-1 (Exherin) on an every three-week schedule in patients whose tumors express the molecular target,
This settlement arises out of a suit brought by Glaxo against Bentley in October 2003, alleging that Bentley had violated Glaxo’s patents in the production of paroxetine products
The project, the largest of its kind in China, was launched with the signing of a memorandum of understanding by Wang Longde, vice minister of health, and Judy
The patent covers combination therapy for modifying glucose metabolism comprising administration of a dipeptidyl peptidase IV (DPIV) inhibitor and a further therapeutic agent, such as metformin. OSI has
Researchers from the Reeve Irvine Research Center at the University of California, Irvine have published studies demonstrating that human embryonic stem cells (hESC)-derived oligodendroglial progenitor cells (OPCs) could